T cell responses to SARS-CoV-2
A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
Covid-19 vaccines—immunity, variants, boosters
DH Barouch - New England Journal of Medicine, 2022 - Mass Medical Soc
Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine …
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine …
[HTML][HTML] A multinational Delphi consensus to end the COVID-19 public health threat
JV Lazarus, D Romero, CJ Kopka, SA Karim… - Nature, 2022 - nature.com
Despite notable scientific and medical advances, broader political, socioeconomic and
behavioural factors continue to undercut the response to the COVID-19 pandemic 1, 2. Here …
behavioural factors continue to undercut the response to the COVID-19 pandemic 1, 2. Here …
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
P Irrgang, J Gerling, K Kocher, D Lapuente… - Science …, 2022 - science.org
RNA vaccines are efficient preventive measures to combat the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 …
syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 …
[HTML][HTML] Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged≥ 65 years …
D Surie - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated
Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States …
Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States …
Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused
considerable morbidity and mortality worldwide. The protection provided by vaccines and …
considerable morbidity and mortality worldwide. The protection provided by vaccines and …
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
L Pérez-Alós, CB Hansen… - Nature …, 2023 - nature.com
The heterogeneity of the SARS-CoV-2 immune responses has become considerably more
complex over time and diverse immune imprinting is observed in vaccinated individuals …
complex over time and diverse immune imprinting is observed in vaccinated individuals …
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Y Li, MC Choudhary, J Regan, J Boucau… - Science translational …, 2024 - science.org
Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
Vaccine hesitancy: contemporary issues and historical background
RF Nuwarda, I Ramzan, L Weekes, V Kayser - Vaccines, 2022 - mdpi.com
Vaccination, despite being recognized as one of the most effective primary public health
measures, is viewed as unsafe and unnecessary by an increasing number of individuals …
measures, is viewed as unsafe and unnecessary by an increasing number of individuals …